Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

Edluar®

	Next higher product group	Hypnotica / Sedativa_oo (qm)
	Status	2012-03-06 sales existent
	Organisation	Orexo AB (OMX Nordic List, Mid Cap: ORX)
	Group	Orexo (Group)

Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for pharmaceutical

[1] Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford....
[2] Domain Therapeutics S.A.. (4/17/24). "Press Release: Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer". Strasbourg, Motnreal, QC & Boston, MA....
[3] MedinCell S.A.. (4/16/24). "Press Release: Medincell Enters into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies". Montpellier....
[4] Naobios. (4/15/24). "Press Release: Naobios and Sumagen Sign Exclusive Partnership to Develop HIV Vaccine". Nantes....
[5] Roche. (4/11/24). "Press Release: Roche Granted FDA Breakthrough Device Designation for Blood Test to Support Earlier Alzheimer's Disease Diagnosis". Basel....
[6] FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg....
[7] Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY....
[8] CRS Clinical Research Services Management GmbH. (4/10/24). "Press Release: CRS Appoints Catherine Canales as New Chief Commercial Officer to Fuel Strategic Development and International Growth". Mannheim....
[9] Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai....
[10] Seaport Therapeutics. (4/9/24). "Press Release: Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines". Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]